| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/26/2023 | 83.75% | Barclays | $11.5 → $9.5 | Maintains | Overweight |
| 09/11/2023 | 344.87% | TD Cowen | $26 → $23 | Maintains | Outperform |
| 08/28/2023 | 112.77% | RBC Capital | → $11 | Reiterates | Outperform → Outperform |
| 08/21/2023 | 190.14% | JP Morgan | $14 → $15 | Maintains | Overweight |
| 08/16/2023 | 402.9% | TD Cowen | $29 → $26 | Maintains | Outperform |
| 07/17/2023 | 112.77% | RBC Capital | → $11 | Reiterates | Outperform → Outperform |
| 05/30/2023 | 112.77% | RBC Capital | → $11 | Reiterates | Outperform → Outperform |
| 04/10/2023 | 112.77% | RBC Capital | $10 → $11 | Maintains | Outperform |
| 04/05/2023 | 325.53% | Tigress Financial | → $22 | Reiterates | → Buy |
| 03/30/2023 | 151.45% | Goldman Sachs | $12 → $13 | Maintains | Buy |
| 01/13/2023 | 151.45% | Barclays | $12 → $13 | Maintains | Overweight |
| 11/16/2022 | 460.93% | Cowen & Co. | $27 → $29 | Maintains | Outperform |
| 11/09/2022 | 132.11% | Wells Fargo | → $12 | Initiates Coverage On | → Overweight |
| 10/12/2022 | 151.45% | Goldman Sachs | $15 → $13 | Maintains | Buy |
| 08/17/2022 | 422.24% | Cowen & Co. | $26 → $27 | Maintains | Outperform |
| 08/17/2022 | 190.14% | Goldman Sachs | $18 → $15 | Maintains | Buy |
| 08/17/2022 | 228.82% | Barclays | $21 → $17 | Maintains | Overweight |
| 06/13/2022 | 325.53% | Tigress Financial | → $22 | Initiates Coverage On | → Buy |
| 04/04/2022 | 209.48% | Citigroup | $21 → $16 | Maintains | Buy |
| 03/21/2022 | 306.19% | RBC Capital | $23 → $21 | Maintains | Outperform |
| 03/16/2022 | 306.19% | Barclays | $24 → $21 | Maintains | Overweight |
| 11/18/2021 | 325.53% | JP Morgan | $20 → $22 | Upgrades | Neutral → Overweight |
| 11/08/2021 | 364.22% | Barclays | → $24 | Initiates Coverage On | → Overweight |
| 11/08/2021 | 460.93% | Goldman Sachs | → $29 | Initiates Coverage On | → Buy |
| 11/08/2021 | 422.24% | Cowen & Co. | → $27 | Initiates Coverage On | → Outperform |
| 11/08/2021 | 344.87% | RBC Capital | → $23 | Initiates Coverage On | → Outperform |
| 11/08/2021 | 286.85% | JP Morgan | → $20 | Initiates Coverage On | → Neutral |
What is the target price for IHS Holding (IHS)?
The latest price target for IHS Holding (NYSE: IHS) was reported by Barclays on September 26, 2023. The analyst firm set a price target for $9.50 expecting IHS to rise to within 12 months (a possible 83.75% upside). 14 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for IHS Holding (IHS)?
The latest analyst rating for IHS Holding (NYSE: IHS) was provided by Barclays, and IHS Holding maintained their overweight rating.
When is the next analyst rating going to be posted or updated for IHS Holding (IHS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of IHS Holding, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for IHS Holding was filed on September 26, 2023 so you should expect the next rating to be made available sometime around September 26, 2024.
Is the Analyst Rating IHS Holding (IHS) correct?
While ratings are subjective and will change, the latest IHS Holding (IHS) rating was a maintained with a price target of $11.50 to $9.50. The current price IHS Holding (IHS) is trading at is $5.17, which is out of the analyst's predicted range.